{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:05:04Z","timestamp":1779714304242,"version":"3.53.1"},"reference-count":26,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Introduction: Congenital myasthenic syndrome (CMS) is a rare hereditary disorder of the neuromuscular junction caused by pathogenic variants that affect acetylcholine transmission. We report three pediatric cases with CMS, including a rare homozygous CHRNE mutation previously described only once, a novel CHRNE compound heterozygous variant, and two novel DPAGT1 variants associated with limb-girdle CMS (LG-CMS), thereby expanding the known genetic and phenotypic spectrum of the disorder. Case presentation: The first patient, a 4-year-old girl born to consanguineous parents, presented with bilateral ptosis and fatigable weakness since infancy. Whole-genome sequencing revealed a homozygous CHRNE variant, c.991C&gt;T. The second patient, a 4-year-old boy born to non-consanguineous parents, presented with congenital bilateral ptosis and ophthalmoplegia without generalized weakness. Genetic analysis identified compound heterozygous CHRNE variants, c.905C&gt;G and c.1040T&gt;C. Both patients demonstrated marked improvement with pyridostigmine therapy. The third patient, a 3-year-old girl born to non-consanguineous parents, presented with severe limb weakness requiring assistance in walking and performing daily activities with minimal ocular involvement, suggesting a diagnosis of LG-CMS. Genetic testing identified two novel variants in the DPAGT1 gene in the compound heterozygous form, c.710G&gt;T and c.858C&gt;A. The initial response to pyridostigmine diminished over time. Conclusions: These cases underscore the phenotypic heterogeneity of CMS, even within the same genetic subtype, and expand the existing mutational spectrum of CHRNE and DPAGT1 genes. This study also highlights the essential role of molecular diagnosis in distinguishing CMS from other neuromuscular disorders. Early genetic confirmation facilitates genotype-targeted therapy, prevents inappropriate immunosuppression, and enables informed reproductive counseling.<\/jats:p>","DOI":"10.3390\/neurolint18060102","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:57:44Z","timestamp":1779710264000},"page":"102","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic Diversity in Pediatric Congenital Myasthenic Syndrome: Insights from CHRNE and DPAGT1 Variants"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0495-0378","authenticated-orcid":false,"given":"Aya","family":"Ewida","sequence":"first","affiliation":[{"name":"College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7490-4480","authenticated-orcid":false,"given":"Dima","family":"Al-Qaimari","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaid","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, King\u2019s College Hospital London, Dubai 2623, United Arab Emirates"},{"name":"College of Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikil","family":"Sudarsan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, King\u2019s College Hospital London, Dubai 2623, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13023-019-1025-5","article-title":"Congenital myasthenic syndromes","volume":"14","author":"Finsterer","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e0347","DOI":"10.1097\/MD.0000000000010347","article-title":"CHRNE compound heterozygous mutations in congenital myasthenic syndrome: A case report","volume":"97","author":"Yang","year":"2018","journal-title":"Medicine"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chang, T., Cossins, J., and Beeson, D. (2016). A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: A case report. BMC Neurol., 16.","DOI":"10.1186\/s12883-016-0716-y"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2174\/1570159X18666200729092332","article-title":"Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports","volume":"19","author":"Huang","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e12952","DOI":"10.1111\/nan.12952","article-title":"Pathogenic DPAGT1 variants in limb-girdle congenital myasthenic syndrome (LG-CMS) associated with tubular aggregates and ORAI1 hypoglycosylation","volume":"50","author":"Sternberg","year":"2024","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajhg.2012.05.022","article-title":"Mutations in DPAGT1 Cause a Limb-Girdle Congenital Myasthenic Syndrome with Tubular Aggregates","volume":"91","author":"Belaya","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/jnnp-2012-304716","article-title":"Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1","volume":"84","author":"Finlayson","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/WNL.0000000000000435","article-title":"DPAGT1 myasthenia and myopathy: Genetic, phenotypic, and expression studies","volume":"82","author":"Selcen","year":"2014","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.nmd.2013.03.003","article-title":"Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1","volume":"23","author":"Basiri","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.nmd.2014.11.013","article-title":"Congenital Myasthenic Syndrome caused by mutations in DPAGT","volume":"25","author":"Klein","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"ref_11","first-page":"e22","article-title":"Congenital myasthenic syndrome due to DPAGT 1 mutations mimicking congenital myopathy in an Irish family","volume":"25","author":"Murphy","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101906","DOI":"10.1016\/j.scr.2020.101906","article-title":"Establishment of (JUCTCi007-A) iPSC line from a patient with congenital myasthenic syndrome (CMS) carrying a homozygous mutation p.Arg331Trp (c.991C > T) in the CHRNE gene","volume":"47","author":"Ababneh","year":"2020","journal-title":"Stem Cell Res."},{"key":"ref_13","unstructured":"(2026, March 06). HGMD\u00ae Home Page n.d. Available online: https:\/\/www.hgmd.cf.ac.uk\/ac\/index.php."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/6.5.753","article-title":"Congenital Myasthenic Syndromes due to Heteroallelic Nonsense\/Missense Mutations in the Acetylcholine Receptor Subunit Gene: Identification and Functional Characterization of Six New Mutations","volume":"6","author":"Ohno","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","first-page":"28","article-title":"Congenital myasthenic syndrome: Phenotypic variability in patients harbouring p.T159P mutation in CHRNE gene","volume":"36","author":"Ardissone","year":"2017","journal-title":"Acta Myol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ohno, K., Ohkawara, B., Shen, X.-M., Selcen, D., and Engel, A.G. (2023). Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes\u2014A Comprehensive Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043730"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/WNO.0b013e3181f50bea","article-title":"Congenital Myasthenic Syndrome Due to Homozygous CHRNE Mutations: Report of Patients in Arabia","volume":"31","author":"Salih","year":"2011","journal-title":"J. Neuro-Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/ETLS20180100","article-title":"Targeted therapies for congenital myasthenic syndromes: Systematic review and steps towards a treatabolome","volume":"3","author":"Thompson","year":"2019","journal-title":"Emerg. Top. Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.47391\/JPMA.21352","article-title":"Salbutamol in the management of congenital myasthenic syndrome (CMS) and associated IgA and IgG Deficiency","volume":"75","author":"Abdullah","year":"2025","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Garc\u00eda De La Banda, M., Simental-Aldaba, E., Fahmy, N., Sternberg, D., Blondy, P., Quijano-Roy, S., and Malfatti, E. (2022). Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.909715"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3233\/JND-221675","article-title":"Novel DPAGT1 Gene Mutation in Two Twins with Congenital Myasthenic Syndrome and a Review of the Literature","volume":"10","author":"Cheli","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pediatrneurol.2024.06.002","article-title":"Congenital Myasthenic Syndromes in Belgium: Genetic and Clinical Characterization of Pediatric and Adult Patients","volume":"158","author":"Smeets","year":"2024","journal-title":"Pediatr. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/aws016","article-title":"A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance","volume":"135","author":"Webster","year":"2012","journal-title":"Brain"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/18\/6\/102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:40:33Z","timestamp":1779712833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/18\/6\/102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["neurolint18060102"],"URL":"https:\/\/doi.org\/10.3390\/neurolint18060102","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}